InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Explore the full record of transactions filed by Lamothe Jeffrey G., Chief Financial Officer. Director active across 1 company, notably Aptevo Therapeutics Inc.. Aggregated, 10 disclosures have been published. Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Lamothe Jeffrey G.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
961 sharesCommon StockSEC:0001193125-26-343079:0
5 sharesCommon Stock (post-reverse split May ACTIVE)SEC:0000950170-25-097267:0
3 sharesCommon StockSEC:0000950170-25-032197:0
42 sharesCommon StockSEC:0000950170-24-094816:0
5,500 sharesCommon StockSEC:0000950170-24-025915:0
1,833 sharesCommon StockSEC:0000950170-24-009003:0
11,979 sharesCommon StockSEC:0001209191-23-045263:0
3,666 sharesCommon StockSEC:0001209191-23-016789:0
1,834 sharesCommon StockSEC:0001209191-23-005420:0
1,833 sharesCommon StockSEC:0001019056-22-000112:0
10 of 10 declarations
About Lamothe Jeffrey G.
Lamothe Jeffrey G. is Directeur Financier and is linked to Aptevo Therapeutics Inc., where he is President and CEO. The declarant has 10 filings in total, and, across the sampled recent filings held, the period runs from 2022-02-01 to 2026-08-10; the most common transaction type is Levée d'options.
